Implanet received approval under the CE Mark to market the JAZZ® Passer, part of the company’s JAZZ spinal fusion platform.
The device, designed in response to voice of surgeon customer, facilitates placement of the JAZZ band around anatomical structures in posterior fixation procedures. It includes spinal instruments and braided band technology compatible with all JAZZ platform implant connectors.
Passer received FDA 510(k) clearance at the end of 3Q17.
Sources: Implanet; ORTHOWORLD Inc.
Implanet received approval under the CE Mark to market the JAZZ® Passer, part of the company's JAZZ spinal fusion platform.
The device, designed in response to voice of surgeon customer, facilitates placement of the JAZZ band around anatomical structures in posterior fixation procedures. It includes spinal instruments and braided band...
Implanet received approval under the CE Mark to market the JAZZ® Passer, part of the company’s JAZZ spinal fusion platform.
The device, designed in response to voice of surgeon customer, facilitates placement of the JAZZ band around anatomical structures in posterior fixation procedures. It includes spinal instruments and braided band technology compatible with all JAZZ platform implant connectors.
Passer received FDA 510(k) clearance at the end of 3Q17.
Sources: Implanet; ORTHOWORLD Inc.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.